[1]崔小豪 杨志明.和肽素在急性心肌梗死中的研究进展[J].心血管病学进展,2019,(5):726-729.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
　CUI Xiaohao,YANG Zhiming.Copeptin in Acute Myocardial Infarction[J].Advances in Cardiovascular Diseases,2019,(5):726-729.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.016]
点击复制

和肽素在急性心肌梗死中的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年5期
页码:
726-729
栏目:
综述
出版日期:
2019-08-25

文章信息/Info

Title:
Copeptin in Acute Myocardial Infarction
作者:
崔小豪1 杨志明2
(1. 山西医科大学,山西 太原 030000 ; 2. 山西医科大学第二医院心内科,山西 太原 030000 )
Author(s):
CUI Xiaohao1; YANG Zhiming2
(1. Shanxi Medical University,Taiyuan 030000, Shanxi,China; 2. Department of Cardiology,The Second Hospital of Shanxi Medical University,Taiyuan 030000,Shanxi,China)
关键词:
生物标记物; 和肽素; 诊断; 预后; 急性心肌梗死
Keywords:
Biomarker;  Copeptin;  Diagnosis;  Prognosis;  Acute myocardial infarction
DOI:
10.16806/j.cnki.issn.1004-3934.2019.05.016
摘要:
近年来在心脏病学领域提出了多种生物标记物，研究表明和肽素为一种新的内源性应激标志物，在急性心肌梗死早期释放，可作为早期诊断急性心肌梗死的血清学指标之一，也是评估急性心肌梗死患者临床结局的重要生物标志物，现就和肽素在急性心肌梗死中的研究进展做一综述。
Abstract:
In recent years, a variety of biomarkers have been proposed in the field of cardiology. Studies have shown that copeptin, as a new endogenous stress marker, which releases early in acute myocardial infarction(AMI), can be used as one of the serological indicators for diagnosing AMI at an early stage. Copeptin is also an important biomarker for assessing the clinical outcome of AMI. In this paper, we review the research progress of copeptin in AMI.

参考文献/References:


[1]Ray P,Charpentier S,Chenevier-Gobeaux C,et al.Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease[J].Am J Emerg Med,2012,30(3):440-448.

[2]Elshafei A,Abdalla G,El-Motaal OA,et al.Copeptin:a neuroendocrine biomarker in acute myocardial infarction[J].Annu Rev Res Biol,2013,3:1040-1054.

[3]Yilman M,Erenler AK,Baydin A.Copeptin:a diagnostic factor for critical patients[J].Eur Rev Med Pharmacol Sci,2015,19(16):3030-3036.

[4]Jochberger S,Luckner G,Mayr VD,et al.Course of vasopressin and copeptin plasma concentrations in a patient with severe septic shock[J].Anaesth Intensive Care,2006,34(4):498-500.

[5]Katan M,Christ-Crain M.The stress hormone copeptin:a new prognostic biomarker in acute illness[J].Swiss Med Wkly,2010,140:13101.

[6]M?ckel M,Searle J,Hamm C,et al.Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome(ACS):a randomized, controlled clinical process study[J].Eur Heart J,2015,36(6):369-376.

[7]Lippi G,Plebani M,di Somma S,et al.Considerations for early acute myocardial infarction rule-out for emergency department chest pain patients:the case of Copeptin[J].Clin Chem Lab Med,2012,50(2):243-253.

[8]Morgenthaler NG,Struck J,Alonso C,et al.Assay for the measurement of copeptin,a stable peptide derived from the precursor of vasopressin[J].Clin Chem,2006,52(1):112-119.

[9]Khan SQ,Dhillon OS,O’Brien RJ,et al.C-terminal provasopressin(copeptin) as a novel and prognostic marker in acute myocardial infarction:Leicester Acute Myocardial Infarction Peptide(LAMP) study[J].Circulation,2007,115(16):2103-2110.

[10]Reichlin T,Hochholzer W,Stelzig C,et al.Incremental value of copeptin for rapid rule out of acute myocardial infarction[J].J Am Coll Cardiol,2009,54(1):60-68.

[11]Gu YL,Voors AA,Zijlstra F,et al.Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction[J].Clin Res Cardiol,2011,100(12):1069-1076

[12]Abd El Baky Mahmoud M, Shaaban MAA, Ali Ramzy A.Clinical role of serum copeptin in acute coronary syndrome[J].Egypt Heart J,2018,70(3):155-159.

[13]Ay MO,Erenler AK,Dogan T,et al.Diagnostic value of copeptin in acute myocardial infarction[J].Eur Rev Med Pharmacol Sci,2017,21(7):1576-1582.

[14]Boeddinghaus J,Twerenbold R,Nestelberger T,et al.Clinical validation of a novel high-sensitivity cardiac troponin I assay for early diagnosis of acute myocardial infarction[J].Clin Chem,2018,64(9):1347-1360.

[15]Mueller-Hennessen M,Lindahl B,Giannitsis E,et al.Combined testing of copeptin and high-sensitivity cardiac troponin T at presentation in comparison to other algorithms for rapid rule-out of acute myocardial infarction[J].Int J Cardiol,2019,276:261-267.

[16]Wildi K,Zellweger C,Twerenbold R,et al.Incremental value of copeptin to highly sensitive cardiac troponin I for rapid rule-out of myocardial infarction[J].Int J Cardiol,2015,190:170-176.

[17]Pedersen CK,Stengaard C,S?ndergaard H,et al.A multicentre,randomized,controlled open-label trial to compare an Accelerated Rule-Out protocol using combined prehospital copeptin and in-hospital high sensitive troponin with standard rule-out in patients suspected of acute Myocardial Infarction—the AROMI trial[J].Trials,2018,19(1):683.

[18]Ananth V ,Beig JR,Tramboo NA,et al.Does plasma copeptin level at admission predict final infarct size in ST-elevation myocardial infarction[J].Int J Cardiol,2016,219:326-330.

[19]Narayan H,Dhillon OS,Quinn PA,et al.C-terminal provasopressin(copeptin) as a prognostic marker after acute non-ST elevation myocardial infarction: Leicester Acute Myocardial Infarction PeptideⅡ(LAMPⅡ) study[J].Clin Sci(Lond),2011,121(2):79-89.

[20]Afzali D,Erren M,Pavenst?dt HJ,et al.Impact of copeptin on diagnosis, risk stratification, and intermediate-term prognosis of acute coronary syndromes[J].Clin Res in Cardiol,2013,102(10):755-763.

[21]Lattuca B,Sy V,Nguyen LS.et al.Copeptin as a prognostic biomarker in acute myocardial infarction[J].Int J Cardiol,2019,274(1):337-341.

[22]Choi HJ,Kim MC,Sim DS,et al.Serum copeptin levels predict clinical outcomes after successful percutaneous coronary intervention in patients with acute myocardial infarction[J].Ann Lab Med,2018,38(6):538-544.

[23]厉菁,袁义强,王明杰.Copeptin与急性心肌梗死合并新发心房颤动的关系分析[J].国际医药卫生导报,2018,24(5):647-649.

[24]Mueller C,Mockel M,Giannitsis E,et al.Use of copeptin for rapid rule-out of acute myocardial infarction[J].Eur Heart J Acute Cardiovasc Care,2018,7(6):570-576.

[25]Winther JA,Brynildsen J,H?iseth AD,et al.Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study[J].Respir Res,2017,18(1):184.

[26]Sang G,Du JM,Chen YY,et al.Plasma copeptin levels are associated with prognosis of severe acute pancreatitis[J].Peptides,2014,51:4-8.

[27]Perovic E,Mrdjen A,Harapin M. Diagnostic and prognostic role of resistin and copeptin in acute ischemic stroke[J].Top Stroke Rehabil,2017,24(8):614-618.

[28]Jiang L,Feng B,Gao D,et al.Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHEⅡscores in patients with sepsis[J]. J Int Med Res,2015,43(2):188-195.

[29]Müller B,Morgenthaler N,Stolz D,et al.Circulating levels of copeptin,a novel biomarker,in lower respiratory tract infections[J].Eur J Clin Invest,2007,37(2):145-152.

[30]Christ-Crain M,Morgenthaler NG,Fenske W. Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia[J].Best Pract Res Clin Endocrinol Metab,2016,30(2):235-247.

[31]Topaloglu TS,Ozben S,Koseoglu BM. Plasma copeptin levels in patients with restless legs syndrome[J].Acta Neurol Scand,2018,137(3):316-320.

[32]Bhandari SS,Loke I,Davies JE,et al.Gender and renal function influence plasma levels of copeptin in healthy individuals[J].Clin Sci(Lond),2009,116(3):257-263.

更新日期/Last Update: 2019-12-24